First Look Analysts Research Calls for Monday, April 17
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Biogen (BIIB) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $346 > Dexcom (DXCM) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Biogen (BIIB) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $346
> Dexcom (DXCM) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to $138
> HP Inc. (HPQ) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $35
> Lumentum (LITE) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $60
> Ollie’s Bargain Outlet (OLLI) upgraded to Neutral from Underweight at JP Morgan; tgt raised to $66
> Sallie Mae (SLM) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $17
> Taiwan Semiconductor Manufacturing (TSM) upgraded to Positive from Neutral at Susquehanna; tgt $126
Downgrades:
> AES (AES) downgraded to Peer Perform from Outperform at Wolfe Research
> AngioDynamics (ANGO) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $13
> Catalent (CTLT) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $53
> Commscope (COMM) downgraded to Hold from Buy at Jefferies; tgt lowered to $5.50
> ConocoPhillips (COP) downgraded to Neutral from Buy at Mizuho; tgt lowered to $128
> Dell (DELL) downgraded to Neutral from Overweight at JP Morgan; tgt $47
> Essex Property (ESS) downgraded to Underperform from Market Perform at BMO Capital Markets; tgt lowered to $200
> Infosys (INFY) downgraded to Neutral from Outperform at Macquarie
> Kaltura (KLTR) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $1.75
> Meta Platforms (META) downgraded to Neutral from Buy at New Street; tgt $220
> Ovintiv (OVV) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $40
> PENN Entertainment (PENN) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
> Teradyne (TER) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $81
> Texas Roadhouse (TXRH) downgraded to Mkt Perform from Outperform at Raymond James
> ViewRay (VRAY) downgraded to Hold from Buy at Jefferies; tgt lowered to $1.25
> Wolfspeed (WOLF) downgraded to Neutral from Overweight and placed on Negative Catalyst Watch at JP Morgan; tgt lowered
Others:
> Autodesk (ADSK) initiated with an Outperform at William Blair
> Check Point Software (CHKP) initiated with an Outperform at Wolfe Research; tgt $151
> Corsair Gaming (CRSR) initiated with a Neutral at Goldman; tgt $20
> Fluence (FLNC) initiated with a Market Perform at BMO Capital Markets; tgt $24
> Hilton Grand Vacations (HGV) initiated with a Neutral at BofA Securities; tgt $50
> Rallybio (RLYB) initiated with a Buy at H.C. Wainwright; tgt $18
> Replimune (REPL) assumed with an Overweight at Piper Sandler; tgt $44
> STAAR Surgical (STAA) initiated with a Neutral at Piper Sandler; tgt $65
> Stem (STEM) initiated with a Market Perform at BMO Capital Markets; tgt $3.50
> Travel + Leisure Co (TNL) initiated with an Underperform at BofA Securities; tgt $42
> Viridian Therapeutics (VRDN) initiated with an Overweight at Wells Fargo; tgt $46
Contact [email protected] for any questions or corrections.